answersLogoWhite

0

Raboxen is an experimental drug that acts as a monoclonal antibody designed to target and inhibit the activity of the protein known as IL-6. It has been investigated for its potential use in treating various inflammatory and autoimmune conditions, including rheumatoid Arthritis and certain types of cancer. The drug aims to reduce inflammation and improve symptoms by blocking the action of IL-6, which plays a key role in the immune response. As of my last update, raboxen is still under clinical investigation and not yet widely available for general use.

User Avatar

AnswerBot

5d ago

What else can I help you with?

Related Questions